new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Cellectis
Cellectis S a
Cellectis Sa
Cellectis_20100128
  

Cellectis patents

Recent patent applications related to Cellectis. Cellectis is listed as an Agent/Assignee. Note: Cellectis may have other listings under different names/spellings. We're not affiliated with Cellectis, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Cellectis-related inventors




Date Cellectis patents (updated weekly) - BOOKMARK this page
03/23/17 new patent  Modifying messenger rna stability in plant transformations
03/16/17Method of engineering multi-input signal sensitive t cell for immunotherapy
03/09/17Method for in situ inhibition of regulatory t cells
02/23/17Cs1 specific multi-chain chimeric antigen receptor
02/09/17Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
01/19/17Method for generating t-cells compatible for allogenic transplantation
12/15/16Method of engineering chemotherapy drug resistant t-cells for immunotherapy
12/08/16Methods and kits for detecting nucleic acid sequences of interest using dna-binding protein domain
11/17/16Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish
10/27/16New selection of algal-transformed cells using nuclease
10/20/16Cas9 nuclease platform for microalgae genome engineering
10/13/16Method for generating batches of allogeneic t-cells with averaged potency
09/22/16Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
09/22/16Design of rare-cutting endonucleases for efficient and specific targeting dna sequences comprising highly repetitive motives
08/04/16Agrobacterium-mediated genome modification without t-dna integration
08/04/16Rna based method to obtain stably integrated retroviral vectors
06/30/16Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
05/26/16Cd19 specific chimeric antigen receptor and uses thereof
05/26/16Methods for non-transgenic genome editing in plants
05/19/16Brassica engineered to confer herbicide tolerance
05/19/16Improved polynucleotide sequences encoding tale repeats
05/12/16A laglidadg homing endonuclease cleaving the t cell receptor alpha gene and uses thereof
05/12/16Modified diatoms for biofuel production
05/05/16Methods for engineering allogeneic and highly active t cell for immunotheraphy
05/05/16Methods for engineering highly active t cell for immunotheraphy
05/05/16A producing precise dna cleavage using cas9 nickase activity
04/14/16A laglidadg homing endonuclease cleaving the c-c chemokine receptor type-5 (ccr5) gene and uses thereof
04/14/16New compact scaffold of cas9 in the type ii crispr system
02/11/16Potatoes with reduced cold-induced sweetening
12/31/15Tevi chimeric endonuclease and their preferential cleavage sites
12/24/15Potatoes with reduced granule-bound starch synthase
12/10/15Method to counter-select cells or organisms by linking loci to nuclease components
11/05/15Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
10/15/15Coupling herbicide resistance with targeted insertion of transgenes in plants
08/13/15New modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
07/23/15Use of pre t alpha or functional variant thereof for expanding tcr alpha deficient t cells
07/23/15Transcription activator-like effector (tale) fusion protein
01/15/15Methods for engineering allogeneic and highly active t cell for immunotherapy
12/18/14Modifying soybean oil composition through targeted knockout of the fad2-1a/1b genes
08/21/14Method for increasing the efficiency of double-strand-break induced mutagenesis
08/14/14Modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
06/26/14Potatoes with reduced cold-induced sweetening
06/26/14Meganuclease variants cleaving at least one target in the genome of a retrovirus and uses thereof
05/15/14Multi-chain chimeric antigen receptor and uses thereof
05/01/14Custom-made meganuclease and use thereof
04/24/14Method for enhancing the cleavage activity of i-crei derived meganucleases
04/24/14New tale-protein scaffolds and uses thereof
02/06/14Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
01/16/14Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
01/02/14Meganuclease recombination system
09/12/13Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof
08/29/13Use of endonucleases for inserting transgenes into safe harbor loci
08/15/13I-crei homing endonuclease variants having novel cleavage specificity and use thereof
08/01/13Method for improving cleavage of dna by endonuclease sensitive to methylation
07/25/13Meganucleases variants cleaving a dna target sequence in the nanog gene and uses thereof
07/25/13Method for modulating double-strand break-induced homologous recombination
07/18/13Meganuclease variants cleaving a dna target sequence from the rhodopsin gene and uses thereof
06/13/13I-crei variants with new specificity and methods of their generation
06/06/13Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
05/30/13Cell penetrating peptide conjugates for delivering of nucleic acids into a cell
03/07/13Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
02/21/13Meganuclease recombination system
11/29/12Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
10/25/12Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting
10/11/12I-crei meganuclease variants with modified specificity, preparation and uses thereof
Patent Packs
10/11/12Meganuclease variants cleaving at least one target in the genome of a retrovirus and uses thereof
07/05/12Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
10/27/11Meganuclease recombination system
09/15/11Meganuclease variants cleaving a dna target sequence from a glutamine synthetase gene and uses thereof
08/25/11Novel method to generate meganucleases with altered characteristics
08/04/11I-crei homing endonuclease variants having novel cleavage specificity and use therof
07/14/11Chimeric meganuclease enzymes and uses thereof
06/30/11Heterodimeric meganucleases and use thereof
04/21/11Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
03/24/11I-crei meganuclease variants with modified specificity, preparation and uses thereof
02/17/11I-msoi homing endonuclease variants having novel substrate specificity and use thereof
12/23/10Meganuclease variants cleaving a dna target sequence from the mouse rosa26 locus and uses thereof
09/09/10Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
08/12/10Method for enhancing the cleavage activity of i-crei derived meganucleases
07/01/10Obligate heterodimer meganucleases and uses thereof
Patent Packs
06/17/10Hybrid and single chain meganucleases and use thereof
06/10/10Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
06/10/10Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
04/08/10Laglidadg homing endonuclease variants having novel substrate specificity and use thereof
01/28/10I-crei meganuclease variants with modified specificity, preparation and uses thereof
01/28/10Tetrahydrocarbazole derivatives useful as androgen receptor modulators
10/29/09Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
09/03/09Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
09/03/09Meganuclease variants cleaving a dna target sequence from a xeroderma pigmentosum gene and uses thereof
01/28/10Tetrahydrocarbazole derivatives useful as androgen receptor modulators
10/20/16Improved methods for producing mammalian pluripotent stem cell-derived endodermal cells
10/01/15Plants for production of therapeutic proteins
09/03/15Generation of pancreatic endoderm from pluripotent stem cells using small molecules
10/16/14High throughput assembly and cloning polynucleotides comprising highly similar polynucleotidic modules
05/01/14Plants for production of therapeutic proteins
09/27/12Method for modulating the efficiency of double-strand break-induced mutagenesis
10/13/16Method for the generation of compact tale-nucleases and uses thereof
09/22/16Use of meganucelases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
08/06/15Methods for modulating tal specificity
03/05/15New repeat variable diresidues for targeting nucleotides
02/05/15Method to overcome dna chemical modifications sensitivity of engineered tale dna binding domains
12/05/13Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
08/08/13Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
05/09/13Method for the generation of compact tale-nucleases and uses thereof
03/14/13Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
03/07/13Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
12/27/12Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
12/20/12Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
12/13/12Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/29/12Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
Social Network Patent Pack
11/15/12Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/15/12Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
11/15/12Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof
06/07/12Compositions and methods for delivering anti-activated ras antibodies







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Cellectis in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cellectis with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';